{"id":945305,"date":"2026-03-18T08:05:09","date_gmt":"2026-03-18T12:05:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/"},"modified":"2026-03-18T08:05:09","modified_gmt":"2026-03-18T12:05:09","slug":"celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/","title":{"rendered":"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MINNEAPOLIS, March  18, 2026  (GLOBE NEWSWIRE) &#8212; Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth quarter and full year 2025 after the market closes on Wednesday, March 25, 2026. Management will host a webcast\/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.<\/p>\n<p>\n        <strong>Webcast and Conference Call Information<\/strong>\n      <\/p>\n<p>To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this weblink:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=geA6CBCkwugyhMj3H56hicWHYWbfZEkwhmDewL_9C5PPgEXpXW2GOTXoKVDdGcSqYY6r7hWegU4mOF22GnxNNHz-Rj4TUie_SkbuLbsDlNnDU_aT8KaR1zS9nPB3kxsbJUvX7h8oubLb-GEnxcaL5bvgo30Js0Hr3pTbztDySGcWryJE1eajrOF2wp-LAC5ksAVJ8XAgJ-k-M0YHAwgxbViygXqJfNtGvE-VjkLIqhk=\" rel=\"nofollow\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1751140&amp;tp_key=9ff20687c4<\/a>. A replay of the webcast will be available on the Celcuity website following the live event.<\/p>\n<p>\n        <strong>About Celcuity<\/strong>\n      <\/p>\n<p>Celcuity is a clinical-stage biotechnology company pursuing the development of targeted therapies for the treatment of multiple solid tumor indications. The company&#8217;s lead therapeutic candidate is gedatolisib, a potent, pan-PI3K and mTORC1\/2 inhibitor that comprehensively blockades the PI3K\/AKT\/mTOR (\u201cPAM\u201d) pathway. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K\u03b1, AKT, or mTORC1 alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant, with or without palbociclib, in patients with HR+\/HER2- advanced breast cancer (\u201cABC\u201d), has completed enrollment, and the company has reported detailed results for the <em>PIK3CA<\/em> wild-type cohort.\u00a0A Phase 3 clinical trial, VIKTORIA-2, evaluating gedatolisib in combination with a CDK4\/6 inhibitor and fulvestrant as first-line treatment for patients with endocrine resistant HR+\/HER2- ABC, is ongoing. A Phase 1\/2 clinical trial, CELC-G-201, evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing. More detailed information about Celcuity\u2019s active clinical trials can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=J2EcJnE3GzaJhjT-3Gy3ykeCH31a50IZ0N7diM-Ci-HuIpAHpZxryqneBzFP2JalaROh7yFmQFpQend_luWMQHkiGTfY_XGOVmh1uGLmdNgZmNRMK6rxySwf8386B6T_8_GLFPlLQly9vLLZdwD-xFjQu6BJKDyDS1d5uio7oeM=\" rel=\"nofollow\" target=\"_blank\">ClinicalTrials.gov<\/a>. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_woLBexj4WvvTdkZYX3Rf4qcDh01CVGGZak7snPjFauSaAUPJcLlQDyCbXAEKgsAbFKYwbe5zIaRs0d2lc1_YF1KbrZcLcp4D3yUaRg2jZw=\" rel=\"nofollow\" target=\"_blank\">www.celcuity.com<\/a>. Follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oX-ehoQ-BEtQ55OMmrd_Bb_rRLqVcQg8-Iqz0kJTRy9OwTajTKK7jcKAvBfylpj99LkhE0yDeVS7dy_nraxOy8WN1iAeWC9ZdeFG3icDPyQ=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nq0OTyHxWV-Gw48F5pR7NcMkMFkg9ddwmQNJnH7tn6dz8tUmxTjFGUAtR8gKH_P_s_PEXdCr0lduvXnMflV8XA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\u00a0<\/p>\n<p>Celcuity Inc.\u00a0<br \/>Brian Sullivan, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GUiam1R37FHUx3SgB2RMOJ6fX-E1jjUgZCJrSSp6nO8ihQeEPM_nORBa7oIanxVcgpgx3Be0Tm7hgmBaOERcH-uzrqBRAG_BvtWu6M-cJns=\" rel=\"nofollow\" target=\"_blank\">bsullivan@celcuity.com<\/a><br \/>Vicky Hahne, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M6jvKio3WcHZ6tnaDTofQ-DxLZC2wRz9X4py5Dc-Tf4g9U_LdtpRAofMnZ3Xo9ZFqtMjorwNhR9qJ05llcFGgRL3Z4w2_nHQkr5h-pdo4Mc=\" rel=\"nofollow\" target=\"_blank\">vhahne@celcuity.com<\/a>\u00a0\u00a0 <br \/>(763) 392-0123\u00a0\u00a0<br \/>Jodi Sievers, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k6PJPf076I82MkhWDBZ0_3avutFnRDknwCIwXL_bdGqlTSCrPIyXRnsCtK8_huhenFqK5HUebBYh2fO_Qfoy2F4dMwJQkzZPwUBatIDJPKA=\" rel=\"nofollow\" target=\"_blank\">jsievers@celcuity.com<\/a><br \/>(415) 494-9924<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmFkMDZlYjEtZDEwNC00OGQ4LWFkNGEtNjkxZWYzOWEzMTlhLTExNjg1NzMtMjAyNi0wMy0xOC1lbg==\/tiny\/Celcuity-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) &#8212; Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth quarter and full year 2025 after the market closes on Wednesday, March 25, 2026. Management will host a webcast\/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. Webcast and Conference Call Information To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this weblink:\u00a0https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1751140&amp;tp_key=9ff20687c4. A replay of the webcast will be available on the Celcuity website following the live event. About Celcuity &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-945305","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) &#8212; Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth quarter and full year 2025 after the market closes on Wednesday, March 25, 2026. Management will host a webcast\/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. Webcast and Conference Call Information To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this weblink:\u00a0https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1751140&amp;tp_key=9ff20687c4. A replay of the webcast will be available on the Celcuity website following the live event. About Celcuity &hellip; Continue reading &quot;Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-18T12:05:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\\\/Conference Call\",\"datePublished\":\"2026-03-18T12:05:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/\"},\"wordCount\":366,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/\",\"name\":\"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\\\/Conference Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=\",\"datePublished\":\"2026-03-18T12:05:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\\\/Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call - Market Newsdesk","og_description":"MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) &#8212; Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth quarter and full year 2025 after the market closes on Wednesday, March 25, 2026. Management will host a webcast\/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. Webcast and Conference Call Information To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-1865. A live webcast presentation can also be accessed using this weblink:\u00a0https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1751140&amp;tp_key=9ff20687c4. A replay of the webcast will be available on the Celcuity website following the live event. About Celcuity &hellip; Continue reading \"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-18T12:05:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call","datePublished":"2026-03-18T12:05:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/"},"wordCount":366,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/","name":"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=","datePublished":"2026-03-18T12:05:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NDE3NSM3NDkxMDU5IzIxNTcwMDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celcuity-schedules-release-of-fourth-quarter-and-full-year-2025-financial-results-and-webcast-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast\/Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/945305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=945305"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/945305\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=945305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=945305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=945305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}